Thomas DEJOIE

PharmD
Biochemistry laboratory CHU NANTES, France

Poster(s):

• (PA-169) Mass Spectrometry vs. 10-5 MRD Detection by Next-Generation Flow and Sequencing in Multiple Myeloma: Results from the Cassiopeia Clinical Trial
  Wednesday, September 17, 2025